Holen Sie sich die Stockscreener-App
71.51
3.47%
-2.73
Schlusskurs vom Vortag:
$74.24
Offen:
$74.05
24-Stunden-Volumen:
1.05M
Relative Volume:
0.46
Marktkapitalisierung:
$13.79B
Einnahmen:
$217.77M
Nettoeinkommen (Verlust:
$-438.86M
KGV:
-29.67
EPS:
-2.41
Netto-Cashflow:
$-456.33M
1W Leistung:
+0.29%
1M Leistung:
+15.96%
6M Leistung:
+83.62%
1J Leistung:
+142.93%
1-Tages-Spanne:
$71.47
$74.72
1-Wochen-Bereich:
$71.16
$75.10
52-Wochen-Spanne:
$25.34
$75.10
Bridgebio Pharma Inc Stock (BBIO) Company Profile
Firmenname
Bridgebio Pharma Inc
Sektor
Branche
Telefon
(650) 391-9740
Adresse
3160 PORTER DR., PALO ALTO, CA
Vergleichen Sie BBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBIO
Bridgebio Pharma Inc
|
71.53 | 14.31B | 217.77M | -438.86M | -456.33M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bridgebio Pharma Inc Stock (BBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Fortgesetzt | Raymond James | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-14 | Eingeleitet | Jefferies | Buy |
| 2025-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-17 | Eingeleitet | Wolfe Research | Outperform |
| 2025-03-31 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-10-03 | Eingeleitet | Oppenheimer | Perform |
| 2024-09-04 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-21 | Fortgesetzt | Raymond James | Outperform |
| 2024-01-31 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-07 | Eingeleitet | Citigroup | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-18 | Herabstufung | Jefferies | Buy → Hold |
| 2023-04-19 | Eingeleitet | Evercore ISI | Outperform |
| 2023-02-06 | Eingeleitet | Cowen | Outperform |
| 2021-12-27 | Bestätigt | Mizuho | Buy |
| 2021-12-27 | Bestätigt | SVB Leerink | Outperform |
| 2021-09-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-05-21 | Eingeleitet | UBS | Buy |
| 2021-03-22 | Bestätigt | Goldman | Buy |
| 2021-02-22 | Fortgesetzt | JP Morgan | Overweight |
| 2021-02-09 | Fortgesetzt | Goldman | Buy |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-25 | Eingeleitet | BofA/Merrill | Neutral |
| 2020-05-19 | Eingeleitet | BTIG Research | Buy |
| 2020-04-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-02-19 | Eingeleitet | Mizuho | Buy |
| 2019-07-26 | Eingeleitet | Raymond James | Outperform |
| 2019-07-22 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Buy |
| 2019-07-22 | Eingeleitet | JP Morgan | Overweight |
| 2019-07-22 | Eingeleitet | Jefferies | Buy |
| 2019-07-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-07-22 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Bridgebio Pharma Inc Aktie (BBIO) Neueste Nachrichten
89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd - MarketBeat
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 40,000 Shares of Stock - MarketBeat
BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock By Investing.com - Investing.com Canada
Bridgebio Pharma Insider Sold Shares Worth $5,908,476, According to a Recent SEC Filing - marketscreener.com
BridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month HighTime to Buy? - MarketBeat
Price-Driven Insight from (BBIO) for Rule-Based Strategy - news.stocktradersdaily.com
BridgeBio Pharma, Inc. $BBIO Holdings Lifted by Bosun Asset Management LLC - MarketBeat
Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Edgestream Partners L.P. Makes New $1.92 Million Investment in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio Pharma, Inc. $BBIO Position Cut by Affinity Asset Advisors LLC - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Norges Bank Purchases New Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Lymphatic Malformations Market Expected to Experience Major - openPR.com
Legal & General Group Plc Purchases 23,716 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Panagora Asset Management Inc. Boosts Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
72,047 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by Capital Fund Management S.A. - MarketBeat
Rhumbline Advisers Grows Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
How BridgeBio Pharma Inc. stock valuations compare to rivalsMarket Activity Recap & Free Fast Gain Swing Trade Alerts - Newser
BridgeBio Pharma stock hits 52-week high at $72.36 By Investing.com - Investing.com South Africa
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 52-Week HighWhat's Next? - MarketBeat
BridgeBio Pharma stock hits 52-week high at $72.36 - Investing.com
What valuation multiples suggest for BridgeBio Pharma Inc. stockJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - Newser
Prudential Financial Inc. Has $5.07 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
What dividend safety score for BridgeBio Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - Newser
BridgeBio Pharma Surges 170% as New Clinical Partnerships Spark Valuation Debate - Yahoo Finance
Is BridgeBio Pharma Inc. (2CL) stock cheap by valuation metricsJuly 2025 Snapshot & Consistent Income Trade Recommendations - Newser
Can BridgeBio Pharma Inc. (2CL) stock ride next bull market cycleJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Should You Grab This ‘Strong Buy’ Growth Stock With 56% Upside? - Yahoo Finance
Swiss National Bank Has $10.99 Million Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
F m Investments LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
American Century Companies Inc. Buys 62,646 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Why BridgeBio Pharma Inc. stock could rally in 2025Quarterly Performance Summary & AI Powered Market Entry Strategies - BỘ NỘI VỤ
BridgeBio Pharma, Inc. $BBIO Shares Purchased by Cetera Investment Advisers - MarketBeat
Franklin Resources Inc. Acquires 482,149 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Breakout Move: Will BridgeBio Pharma Inc. stock maintain growth storyMarket Performance Recap & Daily Price Action Insights - BỘ NỘI VỤ
BridgeBio (BBIO) Q3 2025 Earnings Call Transcript - The Globe and Mail
(BBIO) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
BridgeBio Pharma’s Attruby Launch Drives Revenue Jump In Q3 - Finimize
BridgeBio to Participate in December Investor Conferences - The Manila Times
BridgeBio Pharma Insider Sold Shares Worth $1,722,224, According to a Recent SEC Filing - MarketScreener
BridgeBio (Nasdaq: BBIO) to present at Piper Sandler and EvercoreISI conferences - Stock Titan
BridgeBio Pharma CEO Kumar Neil sells $1.7m in shares By Investing.com - Investing.com Nigeria
BridgeBio Pharma CEO Kumar Neil sells $1.7m in shares - Investing.com
BridgeBio Pharma CEO Neil Kumar Sells Shares - TradingView
Biotech Stock Could Turn 4-Year Peak Into Records - Finviz
BridgeBio Pharma stock hits 52-week high at 69.69 USD By Investing.com - Investing.com Nigeria
BridgeBio Pharma stock hits 52-week high at 69.69 USD - Investing.com
BridgeBio Pharma: Set For New Commercial Launches After Trial Successes - Seeking Alpha
Creative Planning Boosts Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio Pharma (BBIO) Price Target Increased by 16.55% to 82.90 - MSN
BridgeBio Pharma Independent Director Wen-Chaun Lo Sells 62% Of Holding - simplywall.st
Finanzdaten der Bridgebio Pharma Inc-Aktie (BBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bridgebio Pharma Inc-Aktie (BBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kumar Neil | Chief Executive Officer |
Dec 05 '25 |
Sale |
73.31 |
40,000 |
2,932,563 |
755,686 |
| Kumar Neil | Chief Executive Officer |
Nov 20 '25 |
Sale |
65.84 |
26,156 |
1,722,224 |
228,776 |
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):